Third-party lab testing: 3 independent Janoshik assays on file, most recent test 2026-01-08.
Tracked by Finnrick with 1 pending/unlisted tests.
OptiTropin is listed as active. Tracked by Finnrick with 1 unlisted tests.
| Substance | Measured purity | Test date |
|---|---|---|
| TEST C 250 | not reported | 2026-01-08 |
| TEST C 250 | not reported | 2026-01-07 |
| TEST C 250 | not reported | 2025-12-31 |
None of these 3 assays carry a purity number on the certificate. They confirm the substance was submitted and tested, which is not the same as a measured result and not the same as a failure.
| Status | Active |
|---|---|
| Independent assays on file | 3 |
| Vendor type | Research-use supplier |
These details were read from OptiTropin's own website on 2026-08-17. Pages consulted:
OptiTropin is listed as active and we hold 3 independent Janoshik assays on file. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 3 third-party Janoshik assays for OptiTropin. The most recent is dated 2026-01-08.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Orbitrex Peptides Review, OROS Research Peptides Review, Oupeptide Review.